Alpha Synuclein Protein Monomer (Type 1)
The Alpha Synuclein Protein Monomer (Type 1) is For Research Use Only
Specificity: ~14.46 kDa
Expression System: E. coli
Buffer: PBS pH 7.4
Storage Temperature: -80ºC
Alternative Names: Active Human Recombinant Alpha Synuclein Protein Monomer (Type 1), Active Alpha synuclein monomer, Active Alpha-synuclein monomer, Active Alpha synuclein protein monomer, Active Alpha synuclein monomer, Active Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, Active Alpha synuclein monomers, SYN protein, Parkinson’s disease familial 1 Protein
Product manufactured in Canada by StressMarq.
Alpha-Synuclein (SNCA) is expressed predominantly in the brain, where it is concentrated in presynaptic nerve terminals. Alpha-synuclein is highly expressed in the mitochondria of the olfactory bulb, hippocampus, striatum and thalamus. Functionally, it has been shown to significantly interact with tubulin, and may serve as a potential microtubule-associated protein. It has also been found to be essential for normal development of the cognitive functions; inactivation may lead to impaired spatial learning and working memory. SNCA fibrillar aggregates represent the major non A-beta component of Alzheimers disease amyloid plaque, and a major component of Lewy body inclusions, and Parkinson’s disease. Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin.